Pharmacoepidemiology of testosterone: Curbing off-label prescribing.

Published in: Pharmacoepidemiology and drug safety (2017)

The short-term impact of 2015 PBS criteria showed highly effective and well-targeted curbing of off-label testosterone prescribing. The findings indicate that the main driver for the recent upsurge in testosterone prescribing was treatment of middle-aged men for "Low T" initiated by GPs.

Keyphrases

replacement therapy
primary care
middle aged
adverse drug
smoking cessation
cancer therapy
combination therapy
electronic health record